{"meshTags":["Adenocarcinoma","Adult","Aged","Female","Humans","Lung Neoplasms","Lymphatic Metastasis","Male","Middle Aged","Neoplasm Staging","Neoplasms, Squamous Cell","Receptor, Epidermal Growth Factor","Survival Rate"],"meshMinor":["Adenocarcinoma","Adult","Aged","Female","Humans","Lung Neoplasms","Lymphatic Metastasis","Male","Middle Aged","Neoplasm Staging","Neoplasms, Squamous Cell","Receptor, Epidermal Growth Factor","Survival Rate"],"genes":["erbB","HER","human epidermal growth factor receptor","HER","HERs","HER(1)","HER(2)","HER(4)","HER(1 + 4)","HER(2 + 4)","erbB(1)","erbB(2)","erbB(4)","HER(1)","HER(2)","HER(4)"],"organisms":["9606"],"publicationTypes":["English Abstract","Journal Article"],"abstract":"To study the expression of human epidermal growth factor receptor (HER) family in lung cancer.\nParaffin-embedded tissues from 70 cases of lung cancer (43 cases of squamous cell cancer and 27 cases of adenocarcinoma) and 20 cases of non-cancerous lung diseases were stained for the expression of HERs by means of immunohistochemistry.\nAll HERs were weakly expressed in non-cancerous lung tissues; over-expression of HER(1), HER(2), HER(4), HER(1 + 2), HER(1 + 4) and HER(2 + 4) and HER(1 + 2 + 4) was found in lung cancer and correlated with lymph node metastasis, TNM staging and post-operation survival.\nerbB(1), erbB(2) and erbB(4) are the genes regulating the growth of lung cancer at advanced stages. Targeting the HER(1), HER(2) and HER(4) over-expression might be a new approach to the treatment of lung cancer at advanced stages.","title":"[The expression of erbB/HER family in lung cancer].","pubmedId":"12133326"}